Article info
PDFCommentary
Navigating the ambiguity of invasiveness: is it warranted? A response to De Marco et al
- Correspondence to Dr Nicholas Shane Tito, Psychiatry, Cape Fear Valley Medical Center, Fayetteville, North Carolina, USA; nicholas.s.tito{at}proton.me
Citation
Navigating the ambiguity of invasiveness: is it warranted? A response to De Marco et al
Publication history
- Received October 30, 2023
- Accepted December 23, 2023
- First published January 12, 2024.
Online issue publication
March 20, 2024
Article Versions
- Previous version (20 March 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- What makes a medical intervention invasive?
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US
- Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis
- Mainstreaming genetics into Italian prenatal care: exploring the future implementation of non-invasive prenatal testing (NIPT) in the Italian National Healthcare System using stakeholder interviews
- Non-invasive prenatal diagnosis: progress and potential
- Women’s choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England
- Non-invasive prenatal testing for aneuploidy screening
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing